...
首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Dextran removal by plasmapheresis in a kidney-pancreas transplant recipient with dextran 40-induced osmotic nephrosis.
【24h】

Dextran removal by plasmapheresis in a kidney-pancreas transplant recipient with dextran 40-induced osmotic nephrosis.

机译:在患有右旋糖酐40诱导的渗透性肾病的肾胰腺移植受者中,通过血浆置换去除右旋糖酐。

获取原文
获取原文并翻译 | 示例
           

摘要

Osmotic nephrosis with acute kidney injury can follow the administration of colloid volume expanders and other hypertonic solutions. In the kidney transplant setting, such agents may be used in the donor before organ procurement and in the recipient during the perioperative period. We report a case of acute lung and kidney injury after infusion of dextran 40 immediately after surgery in a kidney-pancreas transplant recipient. Osmotic nephrosis was confirmed by kidney biopsy, and a spectrophotometric assay was used to measure dextran 40 levels in serial serum samples. Plasmapheresis was initiated to decrease dextran 40 levels. Post hoc analysis confirmed that a single session of apheresis was sufficient to rapidly decrease dextran 40 levels without rebound, consistent with a small volume of distribution in a single-compartment model.
机译:具有急性肾损伤的渗透性肾病可以在给予胶体增容剂和其他高渗溶液之后进行。在肾脏移植环境中,可以在器官采购之前在供体中以及围手术期在接受者中使用此类药物。我们报告肾胰腺移植受者术后立即输注右旋糖酐40后发生急性肺和肾脏损伤的情况。肾脏活检证实渗透性肾病,并使用分光光度法测定系列血清样品中的右旋糖酐40水平。启动血浆置换以降低葡聚糖40水平。事后分析证实,单次单采血液分离足以迅速降低右旋糖酐40水平而不会反弹,这与单室模型中的少量分布一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号